Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Extension Study of JM-010 in Parkinson's Disease Patients With Dyskinesia

NCT05516875 is registered in ClinicalTrials.gov with Contera Pharma A/S as lead sponsor.

NCT NCT05516875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05516875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Extension Study of JM-010 in Parkinson's Disease Patients With Dyskinesia
Lead sponsor
Contera Pharma A/S
Phase
Phase 2
Overall status
Terminated
Start date
January 19, 2024
Completion date
June 27, 2024
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesias